Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ANZCTR |
Last refreshed on:
|
13 January 2020 |
Main ID: |
ACTRN12615000194561 |
Date of registration:
|
27/02/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Vegetable intake and blood pressure study
|
Scientific title:
|
The effects of daily consumption of vegetables on blood pressure in prehypertensive and stage 1 hypertensive individuals |
Date of first enrolment:
|
27/04/2015 |
Target sample size:
|
25 |
Recruitment status: |
Completed |
URL:
|
https://anzctr.org.au/ACTRN12615000194561.aspx |
Study type:
|
Interventional |
Study design:
|
Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Crossover;Type of endpoint: Efficacy;
|
Phase:
|
Not Applicable
|
|
Countries of recruitment
|
Australia
| | | | | | | |
Contacts
|
Name:
|
Ms Lauren Blekkenhorst
|
Address:
|
The University of Western Australia
School of Medicine and Pharmacology
GPO Box X2213
Perth WA 6847
Australia |
Telephone:
|
+61 8 9224 0381 |
Email:
|
lauren.blekkenhorst@research.uwa.edu.au |
Affiliation:
|
|
|
Name:
|
Ms Lauren Blekkenhorst
|
Address:
|
The University of Western Australia
School of Medicine and Pharmacology
GPO Box X2213
Perth WA 6847
Australia |
Telephone:
|
+61 8 9224 0381 |
Email:
|
lauren.blekkenhorst@research.uwa.edu.au |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Ambulant men and women;
21-75 years; and
Systolic blood pressure 120-160 mm Hg.
Exclusion criteria: Systolic blood pressure less than 120 mm Hg or greater than 160 mm Hg;
Diastolic blood pressure greater than 100 mm Hg;
Diagnosed type 1 or 2 diabetes or fasting glucose greater than 7.0mmol/L;
Consumption of a diet estimated to contain greater than 200 mg/day of nitrate (volunteers willing to limit nitrate-rich vegetables for a period of 4 weeks before their lead in visit may be included);
Consumption of greater than or equal to 5 serves of vegetables per day;
Being vegan or vegetarian;
Body mass index less than 18.5 kg/m2 and body mass index greater than or equal to 35 kg/m2;
Use of antihypertensive medication;
Use of nitric oxide donors, organic nitrites and nitrates, sildenafil and/or related drugs;
Use of antibacterial mouth wash (volunteers willing to cease using antibacterial mouth wash for a period of 4 weeks before their lead in visit may be included);
Use of antibiotics (within previous 2 months);
Current or recent (less than 12 months) smoking;
History of symptomatic cardiovascular or peripheral vascular disease or chronic kidney disease;
Recent history of a psychiatric illness or other major illnesses such as cancer;
A change in drug therapy likely to influence blood pressure or major secondary outcomes within the previous 3 months, and/or the likelihood that drug therapy would change during the study;
Current or recent (within previous 6 months) significant weight loss or gain (greater than 6% of body weight);
Alcohol intake greater than 140 g per week for women or greater than 210 g per week for men and/or binge drinking behaviour;
Reported participation in night shift work during the study period;
Breastfeeding, pregnancy or planning of pregnancy; and
Inability or unwillingness to follow the study protocol.
Age minimum:
21 Years
Age maximum:
75 Years
Gender:
Both males and females
|
Health Condition(s) or Problem(s) studied
|
Cardiovascular - Hypertension
|
Mental Health - Studies of normal psychology, cognitive function and behaviour
|
Cardiovascular disease;Hypertension; Cardiovascular disease Hypertension
|
Diet and Nutrition - Other diet and nutrition disorders
|
Intervention(s)
|
A randomised, controlled, cross-over trial will be conducted to investigate the effects of different types of vegetables on blood pressure and arterial stiffness.
Each participant will complete three intervention diets of 4 weeks each in random sequence. The first intervention diet will be preceded by a 4 week lead in (washout) period. The first, second and third intervention diets will be separated by a 4 week wash out period.
The intervention diets are: 1. High nitrate diet (~400 mg per day) – with an increase in high-nitrate vegetables (lettuce – all types, spinach, rocket, Chinese leafy greens, other leafy greens, celery, and beetroot). This will involve the consumption of two blended high-nitrate vegetable juices each day: one before breakfast and one before dinner. 2. Low nitrate diet (~100-150 mg per day) – with an increase in low-nitrate vegetables (cauliflower, capsicum, sweet potato, cucumber, tomato, and parsnip). This will involve the consumption of two blended low-nitrate vegetable juices each day: one before breakfast and one before dinner. 3. Low nitrate diet (control diet, ~100 mg per day) – without an increase in vegetables. This will involve the consumption of two blended juice drinks without vegetables each day, matched in energy to juices in diets 1 and 2: one before breakfast and one before dinner.
Participants will be provided with personal blenders and advised on which vegetables/ingredients to buy and blend themselves (all meals will be maintained as usual with the exception of limiting nitrate-rich vegetables where possible). Adherence to the intervention diets will be monitored using juice checklist diaries; food intake questionnaires; and blood, urine and saliva samples.
Participants will attend 9 visits o
|
Primary Outcome(s)
|
Blood pressure response to cognitive stress.
Cognitive stress will be induced using a computerized Cognitive Demand Battery that has been utilized in previous studies and shown to be sensitive to effects of non-pharmaceutical interventions. [Performed at baseline and post visits of each intervention period (total of 6 time points). Continuous blood pressure measurements will be performed for 30 minutes using the Finapres NOVA device during the period of cognitive stress. ]
|
Home blood pressure measured using an automated brachial cuff sphygmomanometer.[Performed by participants daily throughout the entire study duration (24 weeks).]
|
24 hour ambulatory blood pressure measured using a Spacelabs Medical Ambulatory Blood Pressure Monitor.[Performed at baseline and post visits of each intervention period (total of 6 time points). ]
|
Secondary Outcome(s)
|
Arterial stiffness measured as pulse wave velocity and augmentation index using the SphygomoCor XCEL device.[Performed at baseline and post visits of each intervention period (total of 6 time points).]
|
Measure of mood assessed using the Bond-Lader Visual Analogue Mood Scale.[Performed at baseline and post visits of each intervention period (total of 6 time points).]
|
Measures of working memory. This is a composite outcome assessed using the Cognitive Demand Battery which comprises two computerized serial subtraction tasks and a Rapid Visual Information Processing task.[Performed at baseline and post visits of each intervention period (total of 6 time points).]
|
Source(s) of Monetary Support
|
National Health and Medical Research Council
|
Ethics review
|
Status: Approved
Approval date:
Contact:
The University of Western Australia Human Research Ethics Committee
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|